Drugs / Bu Zhong Yi Qi Tang
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT01226524 | Feb 2011 → Aug 2014 | autoimmune thrombocytopenia | Hadassah Medical Organization | Terminated | No outcome recorded Stop: Enrollment |
| Phase 31 trial | ||||||
| Phase 3 | NCT03033290 | Jan 2018 → Jul 2020 | allergic rhinitis | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06881173 | Jun 2022 → Jun 2025 overdue | myasthenia gravis | Cheng, yu-ting | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bu Zhong Yi Qi Tang | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06881173 ↗ |
| Known as | Buzhong Yiqi Decoction | “The experimental group took 15g of Buzhong Yiqi Decoction concentrated powder, 3 times a day, 1 packet each time.” NCT06881173 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Qi-tonifying regimen of traditional Chinese herbal medicine” NCT03033290 ↗ |
| Route | Oral | “Some mice were treated with Bu-Zhong-Yi-Qi-Tang via gavage-fed.” PMID 22361496 ↗ Nov 2011 |